BioLineRx (BLRX) Inventory (2023 - 2025)

BioLineRx has reported Inventory over the past 3 years, most recently at $2.1 million for Q4 2025.

  • Quarterly results put Inventory at $2.1 million for Q4 2025, down 31.7% from a year ago — trailing twelve months through Dec 2025 was $2.1 million (down 31.7% YoY), and the annual figure for FY2025 was $2.1 million, down 31.7%.
  • Inventory for Q4 2025 was $2.1 million at BioLineRx, down from $3.1 million in the prior quarter.
  • Over the last five years, Inventory for BLRX hit a ceiling of $3.1 million in Q4 2024 and a floor of $2.0 million in Q4 2023.
  • Median Inventory over the past 3 years was $2.1 million (2025), compared with a mean of $2.4 million.
  • Biggest five-year swings in Inventory: surged 61.03% in 2024 and later plummeted 31.7% in 2025.
  • BioLineRx's Inventory stood at $2.0 million in 2023, then surged by 61.03% to $3.1 million in 2024, then crashed by 31.7% to $2.1 million in 2025.
  • The last three reported values for Inventory were $2.1 million (Q4 2025), $3.1 million (Q4 2024), and $2.0 million (Q4 2023) per Business Quant data.